Indian Army Drug Tender Central Delhi Enfortumab Daralutamide Tucatinib 2026
Indian Army
CENTRAL DELHI, DELHI
Bid Publish Date
30-Jun-2026, 3:37 pm
Bid End Date
10-Jul-2026, 4:00 pm
EMD
₹9,600
Location
Progress
Quantity
249
Category
Tab Crizotinib 250 mg
Bid Type
Two Packet Bid
Organization: Indian Army (Department Of Military Affairs) seeking procurement of Tab Crizotinib 250 mg, Inj Enfortumab 30 mg, Inj Enfortumab 20 mg, and Tab Zanubrutinib 160 mg in the Central Delhi, Delhi 110002 region. The tender indicates an EMD of ₹9,600 and includes an option clause allowing ±25% quantity variation at contract placement and during the contract currency. There are zero BOQ items listed, implying a centralized or limited-scope procurement with potential delivery-time adjustments based on the option clause. An ATC document is uploaded by the buyer for bidder reference.
The tender emphasizes contract-scale flexibility, with delivery timelines derived from original orders and extended periods calculated by a specified formula. No explicit start/end dates or estimated value are provided. The unique context is military procurement through a government organization with potential for quantity adjustments and extended delivery windows based on purchaser discretion.
EMD amount of ₹9,600 required for bid submission
Quantity may vary ±25% at contract award and during currency
Delivery period determined from original order date with extension rules
ATC document is available to bidders for compliance guidance
Not specified in data; bidders should review ATC document for any payment-related conditions
Delivery period commences from last date of original delivery order; extended time calculated as (Additional quantity ÷ Original quantity) × Original delivery period, minimum 30 days
Not specified in available data; check ATC for LD or penalty clauses
Eligibility to bid for military drug procurement in Central Delhi
Ability to supply Tab Crizotinib 250 mg, Inj Enfortumab 30 mg & 20 mg, Tab Zanubrutinib 160 mg
Compliance with option clause and delivery-time computations
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Tab Crizotinib 250 mg , Inj Enfortumab 30 mg , Inj Enfortumab 20 mg , Tab Zanubrutinib 160 mg
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
OTHER
OTHER
OTHER
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
CENTRAL DELHI, DELHI
Indian Army
WEST DELHI, DELHI
Indian Army
CENTRAL DELHI, DELHI
Indian Army
CENTRAL DELHI, DELHI
Hqids
SOUTH ANDAMAN, ANDAMAN & NICOBAR
Tender Results
Loading results...
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates (similar drug procurement, if applicable)
Financial statements (as required by buyer)
EMD submission document (₹9,600) via online payment or DD
Technical bid documents and compliance statements
OEM authorization or distributorship certificate (if applicable)
ATC reference/document uploaded by buyer
Key insights about DELHI tender market
Bidders should submit the EMD of ₹9,600, provide GST and PAN, attach experience certificates for relevant procurement, and include OEM Authorizations if applicable. Review the ATC document uploaded by the buyer for compliance specifics, and confirm capability to supply Tab Crizotinib, Enfortumab and Zanubrutinib within the ±25% quantity variation and delivery-time rules.
Required documents include GST certificate, PAN card, up-to-date experience certificates, financial statements, EMD submission proof of ₹9,600, technical bid documents, OEM authorization (if applicable), and the ATC reference uploaded by the buyer. Ensure all documents are current and notarized if mandated.
The EMD amount is ₹9,600. Bid submissions must include proof of online payment or demand draft for ₹9,600 as security, along with the other bid documents and the ATC reference provided by the buyer.
Delivery timing starts from the last date of the original delivery order. If quantity increases, the extended time is (Additional quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days. The purchaser may extend to the original delivery period while exercising the option.
The tender covers Tab Crizotinib 250 mg, Inj Enfortumab 30 mg, Inj Enfortumab 20 mg, and Tab Zanubrutinib 160 mg. Ensure batch availability, GMP compliance, and ISI/ISO norms if specified in ATC material.
The ATC document is uploaded by the Buyer and accessible via the tender portal. Bidders should download and review it for any special clauses, payment terms, and delivery conditions before bid submission to ensure full compliance.
While explicit standards are not listed, bidders should review the ATC document for required certifications (e.g., GMP, ISI/ISO where applicable). Ensure that product specifications align with Indian government procurement standards and supplier authorizations are up to date.
The purchaser may vary quantity by ±25% at contract placement and during the currency. Bidder must be prepared to supply increased or decreased quantities at contracted rates, with delivery timelines adjusted per the specified calculation formula.
Indian Army
📍 HYDERABAD, TELANGANA
Border Security Force (bsf)
📍 DHALAI, TRIPURA
Indian Air Force
📍 PUNE, MAHARASHTRA
Border Security Force (bsf)
📍 SOUTH TRIPURA, TRIPURA
Indian Army
📍 INDORE, MADHYA PRADESH
Sign up now to access all documents
Main Document
OTHER
OTHER
OTHER
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS